Analysts think DAWN stock price could increase by 115%
Feb 14, 2026, 12:25 PM
12.37%
What does DAWN do
Day One Biopharmaceuticals, based in Brisbane, California, focuses on developing cancer treatments, including its lead candidate tovorafenib. The company went public on May 27, 2021, and employs 174 people.
11 analysts think DAWN stock price will increase by 115.49%. The current median analyst target is $24.48 compared to a current stock price of $11.36. The lowest analysts target is $17.17 and the highest analyst target is $30.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.